Department of Pharmacology, S.C.B. Medical College and Hospital, Cuttack, Odisha, India.
Department of Pulmonary Medicine, S.C.B. Medical College and Hospital, Cuttack, Odisha, India.
Indian J Tuberc. 2024 Jul;71(3):291-296. doi: 10.1016/j.ijtb.2023.05.015. Epub 2023 May 29.
Tuberculosis-immune reconstitution inflammatory syndrome is an atypical, immoderate immune response mounted by the refurbishing immune system against the mycobacterium tuberculosis, commonly seen in HIV-infected individuals. ART significantly enhances one's immunity. However, this enhancement in immunity also sets off a number of inflammatory processes termed as Immune Reconstitution Inflammatory Syndrome (IRIS).
This observational study was conducted with the aim of assessing the incidence and pattern of TB-IRIS in people living with HIV/AIDS on ART registered at the ART Centre of S.C.B. Medical College and Hospital, Cuttack. They were evaluated for their plasma viral load and CD count at baseline. Thereafter, the plasma viral load was assessed every week and the CD count was assessed fortnightly. Each study participant was followed-up for a period of three months to look for any onset of TB-IRIS.
A total of 286 patients were included the study. The overall incidence of TB-IRIS was 7.7%. The occurrence of paradoxical TB-IRIS was nearly double than ART-associated TB-IRIS. There was a significant rise in the CD cell count in the patients of both paradoxical (p = 0.001) and ART-associated (p = 0.017) TB-IRIS. The plasma viral load at baseline also showed significant differences from the levels documented at the appearance of the TB-IRIS both in both the types i.e. paradoxical (p = 0.001) and ART-associated (p = 0.012) TB-IRIS.
People with HIV/TB coinfection experience high morbidity and death from all kinds of TB-IRIS, necessitating specific attention. As HIV-positive cases and implementation of ART continue to rise, it's vital to quickly rule out TB coinfection.
结核病免疫重建炎症综合征是一种非典型、过度的免疫反应,由修复免疫系统对结核分枝杆菌产生,常见于 HIV 感染者。ART 显著增强了人体的免疫力。然而,这种免疫增强也引发了一系列被称为免疫重建炎症综合征(IRIS)的炎症过程。
本观察性研究旨在评估在 S.C.B.医学院和医院的 ART 中心接受 ART 治疗的 HIV/AIDS 患者中结核病免疫重建炎症综合征(TB-IRIS)的发生率和模式。他们在基线时评估了血浆病毒载量和 CD 计数。此后,每周评估血浆病毒载量,每两周评估 CD 计数。每个研究参与者都进行了为期三个月的随访,以观察是否出现 TB-IRIS。
共有 286 名患者纳入了这项研究。TB-IRIS 的总发生率为 7.7%。与 ART 相关的 TB-IRIS 相比,矛盾性 TB-IRIS 的发生率几乎翻了一番。在矛盾性(p=0.001)和与 ART 相关的(p=0.017)TB-IRIS 患者中,CD 细胞计数均显著升高。在两种类型的 TB-IRIS 中,基线时的血浆病毒载量与 TB-IRIS 出现时的水平也存在显著差异,即矛盾性(p=0.001)和与 ART 相关的(p=0.012)TB-IRIS。
HIV/TB 合并感染的患者因各种类型的 TB-IRIS 而发病率和死亡率较高,需要特别关注。随着 HIV 阳性病例和 ART 的实施不断增加,快速排除 TB 合并感染至关重要。